ZCM
VPHM

Ziegler Capital Management’s VIROPHARMA INC VPHM Stock Holding History

Ziegler Capital Management’s Portfolio VPHM Stock Details VPHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$2M Buy
50,900
+900
+2% +$29.4K 0.17% 162
2013
Q2 		$1.43M Buy
+50,000
New +$1.32M 0.15% 194

Other funds holding VPHM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ziegler Capital Management's VPHM Position: Q3 2013 in Review

Ziegler Capital Management increased its VIROPHARMA INC (VPHM) stake by 1.8% in Q3 2013, buying an estimated $29.4K and bringing the position to 50,900 shares worth $2M. The position accounts for 0.17% of the portfolio, ranked #162.

Ziegler Capital Management first reported a position in VPHM in Q2 2013 and has held it in 2 quarters since. 191 funds tracked by Wall St. Rank hold VPHM as of Q3 2013.

  • Ziegler Capital Management held 50,900 shares of VIROPHARMA INC worth $2M as of Q3 2013.
  • Ziegler Capital Management bought 900 VIROPHARMA INC shares in Q3 2013, an estimated $29.4K.
  • VIROPHARMA INC made up 0.17% of Ziegler Capital Management's portfolio in Q3 2013, its #162 holding.
  • Ziegler Capital Management first reported a position in VIROPHARMA INC in Q2 2013 and has held it in 2 quarters since.
  • 191 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q3 2013.

Based on Ziegler Capital Management's 13F filing for Q3 2013, filed 6 Nov 2013.